Welcome to Targanta Therapeutics Print Page
William Vladuchick, Ph.D.
Vice President, Strategic Development

William C. Vladuchick, Ph.D., retired from Eli Lilly and Company on May 1, 2005, after enjoying a 26-year career. In his last role, he served as Executive Director, Chemical Product Research & Development, having responsibility for the process development laboratories located at the Tippecanoe Laboratories located in Lafayette, for the process research and development laboratories located at the Lilly Technology Center - South in Indianapolis, and at the Lilly Development Centre located in Mont-Saint-Guibert, Belgium.

Dr. Vladuchick graduated from Bucknell University with a Bachelor of Science degree in chemistry in 1973. He completed his doctoral thesis in synthetic organic chemistry in the laboratories of Professor Barry M. Trost at the University of Wisconsin-Madison in 1978.

After completing postdoctoral research with Professor R.B. Woodward at Harvard University in 1979, Dr. Vladuchick began his career at Eli Lilly and Company as a Senior Organic Chemist working in Chemical Process Research. Continuing his growth in the research field, he was promoted to Research Scientist in 1985 and later that year was named Manager, Pharmaceutical Project Management. In 1987, he was named Head, Chemistry, Cancer, and Virology Research, directing the activity of medicinal chemists in various therapeutic areas. He accepted the position of Head, Pharmaceutical Science Research, in 1988, and then as Head, Chemical Process Research, in 1990. He was promoted to Director, Infectious Diseases Research, in 1993, and subsequently named Managing Director, Lilly Research Laboratories - Hamburg, Germany, in 1996. In December of 1999, he was promoted to Executive Director, Early Phase Bulk Development, returning back to Indianapolis, Indiana.